Doctronic, a healthcare technology company built entirely around artificial intelligence, has announced that it has raised 20 million dollars in Series A funding. The investment round was led by Lightspeed Venture Partners, with additional backing from Union Square Ventures, Tusk Ventures, Mantis VC, Seven Stars, and several well-known figures in the AI and healthcare fields, including Dr. Fei-Fei Li, Jay Desai, and Scott Belsky.
This funding marks a significant step forward for the company as it works to make high-quality healthcare more accessible, affordable, and personalized for people across the United States.
The new capital will enable Doctronic to expand its services and accelerate its mission of delivering instant, personalized healthcare. The company plans to grow both its direct-to-consumer offerings and its partnerships with health insurers and healthcare systems. By doing so, it aims to reach more patients, reduce wait times, and lower the cost of care.
Doctronic was founded by Dr. Adam Oskowitz and Matt Pavelle, who saw an opportunity to use generative AI to address one of the most significant problems in American healthcare: the difficulty of getting timely access to quality medical advice. The platform is designed to give people personalized, private health guidance in just minutes. For those who need to speak with a doctor, Doctronic offers video visits with licensed physicians for as little as 39 dollars, often less than the cost of a typical insurance co-pay.
Anyone can use Doctronic’s AI advisor at any time, free of charge. The system provides up to four possible explanations for a person’s symptoms, an assessment of which is most likely, and a clear, structured plan of action. It even generates a SOAP note — the type of medical summary doctors use — so patients can share it with their own healthcare providers. The platform currently handles more than 50,000 visits each week, has facilitated 15 million medical conversations, and serves over one million unique users, all while delivering care at a fraction of the traditional cost.
Doctronic is also building strong relationships with healthcare organizations. This fall, it will begin providing its AI-powered solution to more than 100,000 patients through a partnership with Safe Harbor Health. These collaborations are a key part of the company’s growth strategy, allowing it to integrate into existing healthcare systems and reach more people in need.
What sets Doctronic apart from general-purpose AI assistants is its collective intelligence framework. Instead of relying on a single AI model, the platform utilizes multiple specialized AI agents that collaborate to reason through clinical cases in a structured manner.
Licensed physicians oversee and refine the AI’s decisions, ensuring accuracy and safety. Over time, each interaction adds to a proprietary dataset that links symptoms, treatments, and outcomes, making the system more innovative and more reliable. In fact, Doctronic recently published the first large-scale validation of an autonomous AI doctor, showing a 99.2 percent alignment with the treatment decisions of licensed clinicians.
The company’s growth comes at a time when the U.S. healthcare system is under significant strain. By 2034, the country is expected to face a shortage of up to 124,000 physicians, which could result in nearly one-third of adults lacking regular access to primary care. Doctronic is positioning itself as a valuable partner to doctors, helping patients monitor symptoms, uncover important health insights, and get care more quickly, while easing the workload on an already overburdened system.
Available nationwide, Doctronic has already become a trusted resource for millions of people seeking fast, dependable answers about their health.
How the funding will be used: With this new funding, the company is preparing to scale even more rapidly, aiming to serve millions more Americans and to work hand-in-hand with healthcare providers and insurers to create a more efficient, accessible, and patient-centered healthcare system.
KEY QUOTES:
“Doctronic is scaling at a pace that makes it clear the future of healthcare will be AI-driven. What sets them apart is far more than just speed or convenience, but a fundamentally unique agentic architecture that pairs collective AI intelligence with real clinical oversight. That combination makes Doctronic the trusted front door for millions of patients and positions them to define what next-gen healthcare looks like in America.”
Faraz Fatemi, Partner at Lightspeed Venture Partners
“Whether you are in rural Montana or New York City, it still takes over three weeks to see a primary care doctor, and in many cases a lot more. With Doctronic, the average time to chat with our AI and see one of our clinicians is less than 20 minutes. We often have patients write to us after using the system for the first time with a mixture of both gratitude and disbelief that healthcare can be so easy.”
Dr. Oskowitz
“Hundreds of thousands of people are turning to our AI platform every month and nearly half return within a week, demonstrating that patients want AI-based healthcare because it’s instant, personalized and affordable. Lightspeed is the perfect partner to help us scale from 1 million to 100 million users and beyond. This funding will accelerate our ability to serve more Americans both through our direct-to-consumer channels and emerging business partnerships, while maintaining the security, personalization, and quality that defines Doctronic.”
Pavelle
“Our mission is to remove barriers to care while lowering costs for both employers and employees. Partnering with Doctronic allows us to extend that mission by integrating advanced, AI-powered primary care into our TOTAL Wellness Program. Together, we’re delivering a new standard of accessible, preventive, and affordable healthcare.”
Ryan Herlin, Co-Founder and CEO, Safe Harbor Health
